Original Research
Published on 07 Aug 2025
A pilot transcriptomic study of a novel multitargeted BRT regimen for anti–MDA5 antibody-positive dermatomyositis: improving survival over conventional therapy
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- 416 views